Sign in
CompletedPhase 4

Levothyroxine Dosing in Neonatal Congenital Hypothyroidism

Key facts

Who runs it
Menoufia University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
Phase
Phase 4
People taking part
101 people enrolled
Started
2 Nov 2025
Ended
20 Jul 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Levothyroxine
Record updated
10 August 2026

Who can take part

Age
0 days to 28 days
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Neonates diagnosed with primary congenital hypothyroidism
  • Full-term infants
  • Newly diagnosed
  • Treatment initiated during the neonatal period
  • Written informed parental consent

Who cannot take part

  • Previously thyroid hormone therapy
  • Serious systemic illness affecting thyroid function
  • Central congenital hypothyroidism
  • Prematurity
  • Major congenital malformations

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This randomized controlled trial compared high-dose and moderate-dose levothyroxine as initial therapy for neonates with primary congenital hypothyroidism. One hundred one infants were randomized to receive either approximately 12.85 or 7.65 µg/kg/day. Thyroid function and dose adjustments were assessed every 2 weeks over the first six weeks of treatment to evaluate efficacy and safety.

The 2 groups in the trial

  • High-dose Levothyroxine GroupTreatment being tested

    Participants received initial levothyroxine therapy at a mean dose of 12.85 ± 1.12 µg/kg/day

    Treatment: Levothyroxine

  • Moderate-dose Levothyroxine GroupExisting treatment, for comparison

    Participants received initial levothyroxine therapy at a mean dose of 7.65 ± 0.56 µg/kg/day.

    Treatment: Levothyroxine

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Optimizing Initial Levothyroxine Dosing in Neonates With Congenital Hypothyroidism
Record updated
10 August 2026